Glatiramer Acetate
9013
Approved small_molecule terminated
Quick answer
Glatiramer Acetate for Relapsing Remitting Multiple Sclerosis is a Approved program (small_molecule) at Teva Pharma GmbH with 5 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Relapsing Remitting Multiple Sclerosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated